BlackRock, Inc. 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | Pliant Therapeutics, Inc. PLRX | BlackRock Inc. BLK | 2,104,574 3.400% | -2,696,943 (-56.17%) | Filing |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | BlackRock Inc. BLK | 4,801,517 8.000% | 4,801,517 (New Position) | Filing |